More

    AI Breakthrough: EvolutionaryScale Redefines Biotech with ESM3 Model

    EvolutionaryScale, a groundbreaking AI research lab founded by former Meta employees, has shaken the biotech world with its latest achievement. Just weeks after Meta disbanded its protein team, EvolutionaryScale secured an astounding $142 million in seed funding for its ESM3 model. This milestone in generative AI promises to revolutionize protein design and reshape biological sciences.

    Last August, Meta’s decision to dissolve its Meta-FAIR protein folding team, citing profitability concerns, seemed logical amidst its focus on commercial AI. However, EvolutionaryScale’s rapid ascent has proven otherwise. ESM3, their latest generative AI model, has emerged as a beacon of innovation, unlocking unprecedented possibilities in biological programming.

    Founded in July 2023 by Chief Scientist Alexander Rives and other former Meta FAIR members, EvolutionaryScale specializes in developing large language models for biological applications. Their journey from Meta’s setback to securing substantial funding underscores their resilience and vision for advancing AI in biotechnology.

    ESM3’s capabilities extend beyond traditional protein design, leveraging deep learning on a dataset of 2.78 billion proteins to simulate, understand, and create new biological systems. Notably, it has already made strides in protein folding technology, aiding global scientific efforts in disease response and environmental conservation.

    EvolutionaryScale’s commitment to open research and safety protocols has garnered support from over 160 stakeholders worldwide. Their collaborative approach aims to harness AI’s potential responsibly, ensuring impactful innovations in medicine, materials science, and environmental sustainability.

    ESM3’s debut marks a pivotal moment in AI’s integration into biology, promising accelerated drug discovery and personalized medicine through data-driven insights. As EvolutionaryScale pioneers synthetic biology and genomic analysis, their quest for smarter, healthier solutions for humanity heralds a new era in biotech innovation.

    Related topics:

    Meta Unveils New AI Text-to-3D Generator, Promising Rapid 3D Modeling

    Zuckerberg Criticizes Tech Race for Singular AI, Advocates Diversity in Developmen

    Meta Faces EU Charges for Digital Markets Act Violation

     

    Recent Articles

    TAGS

    Related Stories